# A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

> **NCT07542704** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Kumquat Biosciences Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Advanced Solid Tumors
- Colorectal Cancer (CRC)
- Non-Small Cell Lung Cancer
- Uterine Cancer
- KRAS G12C Mutations
- KRAS G12S Mutations

## Interventions

- **DRUG:** KQB368

## Key facts

- **NCT ID:** NCT07542704
- **Lead sponsor:** Kumquat Biosciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07542704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07542704, "A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07542704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*